In the News | Press Highlights

The Citizen Health app gathers medical records, genetic reports, imaging studies, and clinical notes from across health care systems, and then uses AI to help families interpret and act on that information. Users can ask questions, track symptoms, and record appointments. “We really think of it as their advocate that knows everything about their information,” CEO Farid Vij says.

Citizen Health announced the launch of its mobile app, bringing its AI Advocate directly to patients and caregivers navigating rare and complex conditions. The app enables users to record and summarize medical visits, receive structured summaries tied to their full longitudinal history, and access and understand their complete medical records in one place, advancing Citizen Health’s mission to empower patients with their data and strengthen real-world evidence.

Citizen Health today announced a new strategic partnership with UCB, a global biopharmaceutical leader in neurological and autoimmune research and development. The multi-year collaboration launches with a focus on epilepsy and five rare disease indications.

Citizen is building an AI advocate that can summarize personal health data, ideally making it easier to use those data in future doctor’s appointments. As a standalone company, Vij said, it can move faster than it might have inside a larger company, especially as AI speeds up what teams are able to do.

At its core, Citizen Health is building a beautiful consumer platform that brings together every piece of a patient’s health journey—clinical data, genetic information, imaging, patient-reported outcomes, and claims.

Citizen Health, a patient-powered platform transforming rare disease care, announced today it has raised $30 million in Series A funding. The round was led by 8VC, with participation from Transformation Capital and Headline, bringing the company's total funding to $44 million since its December 2023 launch.

Why it matters: Citizen aims to equip people with rare diseases, who often face medical dead ends, with an AI-powered advocate to navigate care and interpret records.

“We have our own proprietary database that we have built from scratch over many years to pull together every single e-fax number, every single email for every health information management department or medical records department,” for every single provider or hospital institution in the U.S., Citizen CEO Farid Vij told ...

There was little hope only a few years ago of treatments for kids with ultrarare SLC13A5 or FOXG1 syndromes. Drug companies were loathe to take on the cost of discovering and developing therapies, much less expensive and risky clinical trials, for genetic conditions with only a couple hundred patients.

"We orchestrate Gemini 2.5 Flash and Gemini 2.5 Pro models within a LangGraph‑powered multi‑agent framework, ensuring the most relevant evidence reaches patients and caretakers without hallucinations." - Daniel Wang, CTO, Citizen Health